875550-89-3 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
(2-Chloro-5-isopropylphenyl)boronic acid is used as a research tool for studying and modulating biological processes due to its ability to form reversible covalent bonds with certain biomolecules such as proteins and enzymes.
Used in Cardiovascular Applications:
(2-Chloro-5-isopropylphenyl)boronic acid is used as a novel antiplatelet agent for the treatment and prevention of cardiovascular diseases. It has been investigated for its potential to inhibit platelet aggregation and prevent thrombosis, making it a promising candidate for the development of new antiplatelet drugs.
Used in Synthesis of Pharmaceutical Compounds and Biologically Active Molecules:
(2-Chloro-5-isopropylphenyl)boronic acid is used as a versatile building block for the synthesis of various pharmaceutical compounds and biologically active molecules, contributing to the development of new drugs and therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 875550-89-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,5,5,5 and 0 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 875550-89:
(8*8)+(7*7)+(6*5)+(5*5)+(4*5)+(3*0)+(2*8)+(1*9)=213
213 % 10 = 3
So 875550-89-3 is a valid CAS Registry Number.
875550-89-3Relevant academic research and scientific papers
CETP INHIBITORS
-
, (2008/06/13)
Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula (I), B is a cyclic group other than phenyl, and B has a cyclic substituent at a position that is ortho to the position at which B is connected to the remainder of the structure of Formula (I). The 5-membered ring of Formula (I) has a second cyclic substituent in addition to B.
